Zai Lab
Terry Lau is an experienced professional in the field of medical affairs, currently serving as a Senior Medical Affairs Manager at Zai Lab since June 2021. Previously, Terry held positions as a Medical Affairs Manager at GSK and Boehringer Ingelheim, where roles included Associate Medical Advisor and Medical Science Liaison. With a background as a Medical Science Liaison and involvement in pharmacovigilance at The Janssen Pharmaceutical Companies of Johnson & Johnson, along with experience as a Clinical Research Officer at Roche Pharmaceuticals, Terry has built a robust foundation in the pharmaceutical industry. Academic credentials include a Ph.D. in Biological and Biomedical Sciences from The University of Hong Kong, where a post-doctoral fellowship was completed prior to entering the industry.
This person is not in any offices
Zai Lab
5 followers
Zai Lab Ltd is a biopharmaceutical company. The Company is focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including in the fields of oncology, autoimmune and infectious diseases. The Company has a broad pipeline of proprietary drug candidates that range from discovery stage to late-stage clinical programs. These include three drug candidates with greater China rights and three drug candidates with global rights. The greater China rights drug candidates include Niraparib (ZL-2306), Omadacycline (ZL-2401) and ZL-2301. The global rights drug candidates include Fugan (ZL-3101), ZL-2302 and ZL-1101.